“…Wai (2012) [20]
b. Peterson (2012) [32]
To improve the management of ACS at the point of hospital discharge, across the continuum of careIn 2009, at a median of 96-day- follow-up (range 49–204): • 48 % reported using 4 evidence-based medications (EBMs), with a significant decrease in anti-platelet agents, statins, β blockers and all 4 EBMs • 67 % recalled referral to CR of whom 33 % completed CR and 21 % were still attending CR • 731 GPs (47 % of patient-nominated GPs) participated in survey • 77 % received a discharge summary for patients with ACS at a median time of 3 days (0–41 days) after discharge • Of these 88 % contained a list of prescribed medications; 81 % included dose titration and duration of therapy and 55 % contained details of ongoing risk management • 65 % of GPs rated the quality of information as ‘very good’ to ‘excellent’ • 6 % increase in communication of ACS management plan to GP • 18 % increase in patients with documentated chest pain action plan | Targeted educational intervention can improve management of patients post-ACS Improvements evident in: • Evidence based prescribing • Communication between patient/carer 7 GP • Referrals to CR | • Accuracy of sample representation not documented • Based on medical record documentation and GP survey • Potential for Hawthorne effect • Low response rate of eligible GPs MMAT: 75 % |
ACEi/ARB angiotensin-converting enzyme inhibitor/angiotensin-II receptor blocker, ACS acute coronary syndrome, β B beta-blockers, BMI body mass index, CABG coronary artery bypass grafting, CR cardiac rehabilitation, DAPT dual antiplatelet therapy, EBM evidence-based medication, GP general practitioner, GTN glycerol trinitrate, HDL high-density lipoprotein, LDL low-density lipoprotein, LLD lipid-lowering drugs, MMAT Mixed Methods Appraisal Tool, MI myocardial infarction, NSTEMI Non-ST elevation myocardial infarction, NZ New Zealand, PCI percutaneous coronary intervention, QI quality improvement, TC total cholesterol, UA unstable angina
…”